AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for LUMAKRAS® (Sotorasib)
Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd. (“PREMIA”) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the AmoyDx® Pan Lung Cancer PCR Panel (the “AmoyD
AmoyDx Distributors Annual Meeting 2022
AmoyDx celebrated its regular distributors annual meeting on November 15-16 in Dusseldorf Germany.
Visit AmoyDx at AMP 2022 in Phenix, Arizona
AmoyDx is happy to be participating in this year's Association for Molecular Pathology (AMP) 2022 Annual Meeting and Expo on November 1-5 in Phoenix, Arizona.
AmoyDx and BeiGene Announce Strategic Cooperation on HER2 Companion Diagnostics
Amoy Diagnostics (300685.SZ) and BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235) announced a strategic partnership in the field of companion diagnostics.
AmoyDx to participate in the ESGO 2022
AmoyDx will be in attendance at the 23rd European Congress on Gynaecological Oncology ("ESGO 2022") on October 27-30 in Berlin.
AmoyDx to attend the ESMO Congress 2022
AmoyDx will exhibit at the ESMO Congress 2022 from September 9-13, 2022 in Paris, France.